KKR Enhanced US Direct Lending Fund-L Inc. 8-K

What Happened
KKR Enhanced US Direct Lending Fund-L Inc. filed an 8-K reporting amendments that increase borrowing capacity at two financing subsidiaries and an equity issuance. On December 18, 2025, KKR Enhanced US EvDL Funding II LLC (a wholly owned financing subsidiary) entered into a First Amendment to its BNP Paribas revolving credit facility, raising the facility cap from $200 million to $300 million (no other material terms changed). On the same date, KKR Enhanced US EVDL Funding LLC increased Citibank’s commitment under its loan agreement by $100 million, bringing lender commitments from $500 million to $600 million (the Citibank facility includes an accordion feature allowing up to $1.25 billion). Separately, on December 1, 2025 (finalized December 17, 2025), the Company sold 48,354 common shares for aggregate consideration of $50.0 million to KKR Enhanced US Direct Lending Fund-L Holdings L.P. in a private, unregistered offering.

Key Details

• BNP Credit Facility (via KKR Funding II): maximum facility increased from $200M to $300M (First Amendment dated Dec 18, 2025); BNP Paribas is administrative agent.
• Citibank Credit Facility (via KKR Funding I): Citibank’s commitment increased by $100M, raising total lender commitments from $500M to $600M (Commitment Adjustment Notice dated Dec 18, 2025); facility accordion can expand to $1.25B.
• Equity sale: 48,354 common shares issued (finalized Dec 17, 2025) for $50.0M to an affiliated subscriber; sold pursuant to the Company’s continuous private offering relying on Securities Act exemptions (Section 4(a)(2)/Reg D and/or Reg S).
• Filing: Current Report on Form 8-K filed Dec 29, 2025; exhibits include the First Amendment and Commitment Adjustment Notice.

Why It Matters
These actions increase the Company’s financing capacity and provide more liquidity for the fund’s lending activities by raising available credit at two funding subsidiaries. The $50M private share sale raises additional equity capital from an affiliate, which may support the fund’s capital base or deployment capacity. For investors, the key takeaways are larger committed credit lines (more room to originate or warehouse loans) and a material equity infusion; the filing does not disclose changes to the Company’s investment strategy or projections, and the BNP amendment states no other material terms were altered.